Fig. 1.Plot shows number of deaths from solid tumors per 100 in
excess of expected deaths among Japanese atomic bomb survivors (1950-1990)
versus their dose. Error bars show 95% confidence limits. Plot data are drawn
from [22].
Fig. 2.Plot shows number of deaths from leukemia per 100 in excess
of expected deaths among Japanese atomic bomb survivors (1950-1990) versus
their dose. Error bars show 95% confidence limits. Plot data are drawn from
[22].
Fig. 3.Plot shows standardized rates of death from breast cancer per
million person-years among Canadian women after irradiation in fluoroscopic
examinations versus their radiation dose. Error bars show 95% confidence
limits. Plot data are drawn from
[25].
Fig. 4A.Plots show relative risk of mortality from lung cancer versus
dose to lung, with 95% confidence limits. Plot with expanded vertical scale
shows data from [26]
(circles) and data from
[27] (diamond).
Fig. 4B.Plots show relative risk of mortality from lung cancer versus
dose to lung, with 95% confidence limits. Plot shows data drawn from
[26]; solid line connects data
from Canadian fluoroscopy patients, and dashed line connects data from atomic
bomb survivors.
Fig. 5A.Lung cancer mortality rates (m) in the United States. Plot
data are drawn from [37]. Plot
shows lung cancer mortality rates (age-adjusted) for males versus average
radon level (r) in homes in 1729 counties (90% of nation's population). y =
year.
Fig. 5C.Lung cancer mortality rates (m) in the United States. Plot
data are drawn from [37]. Plot
shows lung cancer mortality rates (age-adjusted) for females versus average
radon level (r) in homes in 1729 counties (90% of nation's population). y =
year.
Fig. 5B.Lung cancer mortality rates (m) in the United States. Plot
data are drawn from [37]. Plot
shows lung cancer mortality rates for males from A, corrected for
smoking prevalence.
Fig. 5D.Lung cancer mortality rates (m) in the United States. Plot
data are drawn from [37]. Plot
shows lung cancer mortality rates for females from C, corrected for
smoking prevalence.